Lamdong Pharmaceutical Joint Stock Company reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was VND 45,290.87 million compared to VND 33,767.43 million a year ago. Net loss was VND 8,392.64 million compared to VND 5,395.32 million a year ago. Basic loss per share from continuing operations was VND 661 compared to VND 425 a year ago. Diluted loss per share from continuing operations was VND 661 compared to VND 425 a year ago.
For the nine months, revenue was VND 138,368.95 million compared to VND 119,502.78 million a year ago. Net loss was VND 27,329.69 million compared to VND 16,342.8 million a year ago. Basic loss per share from continuing operations was VND 2,151 compared to VND 1,287 a year ago. Diluted loss per share from continuing operations was VND 2,151 compared to VND 1,287 a year ago.